Cosmax (192820) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Achieved record-high quarterly revenue of 794.9 KRW bn in Q2 2026, up 27.5% year-over-year, with operating profit rising 21.2% to 73.7 KRW bn.
Growth was broad-based across all regions, with Korea, China, and the US showing strong performance.
Net profit surged 129.0% year-over-year to 50.0 KRW bn, driven by improved operating leverage and non-operating gains.
Financial highlights
Gross profit increased 26.3% year-over-year to 142.5 KRW bn, with gross margin stable.
SG&A expenses rose 32.1% to 68.8 KRW bn, reflecting higher commissions and bad debt expenses.
Profit before tax jumped 145.3% to 64.7 KRW bn.
Assets grew to 2,672.1 KRW bn, and equity increased to 710.4 KRW bn.
Outlook and guidance
Growth momentum expected to continue, especially in the US as it enters a full turnaround phase.
Skincare category expansion and new product launches anticipated to drive further gains.
Latest events from Cosmax
- Q1 2026 revenue up 15.9% YoY and net profit up 312.1%, driven by Korea and China growth.192820
Q1 2026 - Strong revenue and profit growth in 4Q 2025, led by health supplement and holding segments.192820
Q4 2025 - Revenue up 1.0% YoY, but profit declined on one-off costs; R&D and ESG efforts remain strong.192820
Q3 2025 - H1 2025 revenue hit KRW 1,212.1B, with net profit impacted by non-operating expenses.192820
Q2 2025 - Korea and Southeast Asia drove robust profit growth, offsetting China and US weakness.192820
Q3 2024 - H1 2024 revenue reached ₩1,078.3B with net income of ₩54.9B, led by Korea and Southeast Asia growth.192820
Q2 2024 - Q1 2025 revenue and operating profit grew, but net profit fell due to one-off and non-operating losses.192820
Q1 2025 - Record Q4 profit growth driven by Korea and Southeast Asia, with net profit turning positive.192820
Q4 2024